European physicians treat PAD patients using Cook Medical catheter

7 April 2013 (Last Updated April 7th, 2013 18:30)

Cook Medical's ultra low-profile micro-balloon catheter is being used by the European physicians to treat peripheral arterial disease (PAD) patients suffering from arterial lesions in the leg below the knee (BTK).

Cook Medical's ultra low-profile micro-balloon catheter is being used by the European physicians to treat peripheral arterial disease (PAD) patients suffering from arterial lesions in the leg below the knee (BTK).

"The Pliaform can be used along with all sizes except the 1.5 mm diametre devices, according to the company."

Available in 50, 90 and 150cm shaft configurations to accommodate a variety of access points, the Advance Micro 14 PTA balloon catheter has a tip entry profile as small as a 0.018 inch diametre wire.

The device, which has the capability to fit through a 3 French introducer, can be used through the company's 2.9 French pedal access sheath.

The Pliaform balloon texture and hydrophilic coating of the device also reduces friction during the insertion and retraction compared to uncoated devices.

The Pliaform can be used along with all sizes except the 1.5 mm diametre devices, according to the company.

Cook Medical peripheral intervention clinical division vice president Rob Lyles: "This is an ultra low-profile balloon that was engineered for retrograde pedal approach procedures, but is versatile enough for standard antegrade vascular access procedures, as well."

Park Hospital and Heart Centre angiology and cardiology department physician Andrej Schmidt said the centre has obtained positive outcomes with the use of the Micro 14 balloon catheter.

"The ultra low profile of the balloon allows you to pass lesions from both the antegrade and retrograde approaches with the same device," Schmidt added.

The device has also been used to treat patients at medical centres in Germany, France, Sweden, Belgium and the UK.

The company said the low-profile catheter device, which is not approved for sale in the US, will soon be available in many European Union markets.